Search results
Found 16160 matches for
COVID-19 has led to an elevated awareness of threat in the environment and has caused major disruptions to families’ lives, through social distancing, school closures, and now effective lock-down.
SINAPPS2 Background & PPiP2 Recruitment Training Confirmation
The SINAPPS2 Trial is inviting people with acute psychosis symptom(s) and anti-neuronal membrane antibodies who have been identified through PPiP2 study to consent the trial and help testing the efficacy and safety of immunotherapy for antibody-associated psychosis.